Biocryst Pharmaceuticals (BCRX) EBIT (QoQ) (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.47 Bn | 2.12 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.03% |
| Mar 31, 2026 | -369.45% |
| Dec 31, 2025 | 779.95% |
| Sep 30, 2025 | -0.65% |
| Jun 30, 2025 | 40.32% |
| Mar 31, 2025 | 570.87% |
| Dec 31, 2024 | -158.61% |
| Sep 30, 2024 | -12.20% |
| Jun 30, 2024 | 160.47% |
| Mar 31, 2024 | 66.05% |
| Dec 31, 2023 | -257.94% |
| Sep 30, 2023 | 42.42% |
| Jun 30, 2023 | 27.14% |
| Mar 31, 2023 | 38.64% |
| Dec 31, 2022 | -165.47% |
| Sep 30, 2022 | 49.76% |
| Jun 30, 2022 | 30.50% |
| Mar 31, 2022 | 4.25% |
| Dec 31, 2021 | -17.03% |
| Sep 30, 2021 | -50.71% |